Findings from the phase 3 ADAPT SERON trial demonstrated that efgartigimod IV significantly improved MG-ADL total scores in patients who were acetylcholine receptor antibody seronegative. The Food and ...

For adults with severe scabies, higher-dose ivermectin plus permethrin is not superior to standard-dose ivermectin plus permethrin, according to a study published in the May 7 issue of the New England ...

Replacing universal vaccination with targeted birth-dose vaccine recommendation likely to result in increase in infections ...

Bariatric surgery rates rose gradually while GLP-1 receptor agonist prescriptions grew exponentially from 2018 to 2025.

Treatments for COVID-19, gout, nicotine dependence, severe hypertriglyceridemia, and thyroid eye disease are under review.

Based on the current evidence, there is no consistent association between vaccines and serious or long-term health outcomes.

Ozempic tablets are now available; investigational ALS treatment gains FDA Fast Track status; positive results for aficamten ...

Relative vaccine efficacy was 26.6 percent, which met the criteria for noninferiority, superiority, higher-level superiority.

A major amendment has prompted the FDA to extend its review of subcutaneous lecanemab as a starting dose for early Alzheimer disease.

HealthDay News — As an investigation continues into a hantavirus outbreak that killed three passengers and sickened five on an ocean liner, the World Health Organization (WHO) says the odds of broader ...

It’s also not clear that HHS has the regulatory authority to enforce its threat without going through a formal rulemaking process, lawyers and dietitians say.